Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Taraseviciene-Stewart

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The European Respiratory Journal|December 2, 2005
Autoimmunity and pulmonary hypertension: a perspectiveM R Nicolls, L Taraseviciene-Stewart, P R Rai, et al.
Clinics in Chest Medicine|October 10, 2001
The pathobiology of pulmonary hypertension. EndotheliumR M Tuder, C D Cool, M Yeager, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2001
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionL Taraseviciene-Stewart, Y Kasahara, L Alger, et al.
The Journal of Clinical Investigation|December 6, 2000
Inhibition of VEGF receptors causes lung cell apoptosis and emphysemaY Kasahara, R M Tuder, L Taraseviciene-Stewart, et al.
The Journal of Pathology|October 24, 2001
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesisR M Tuder, M Chacon, L Alger, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The European Respiratory Journal|December 2, 2005
Autoimmunity and pulmonary hypertension: a perspectiveM R Nicolls, L Taraseviciene-Stewart, P R Rai, et al.
Clinics in Chest Medicine|October 10, 2001
The pathobiology of pulmonary hypertension. EndotheliumR M Tuder, C D Cool, M Yeager, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2001
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionL Taraseviciene-Stewart, Y Kasahara, L Alger, et al.
The Journal of Clinical Investigation|December 6, 2000
Inhibition of VEGF receptors causes lung cell apoptosis and emphysemaY Kasahara, R M Tuder, L Taraseviciene-Stewart, et al.
The Journal of Pathology|October 24, 2001
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesisR M Tuder, M Chacon, L Alger, et al.
Pageof 1